Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Aminophylline recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Aminophylline (6 total). Check the affected lots below.

Most common reason: Other (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Aminophylline. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Aminophylline recalls on record

none so far in 2026; 6 on record, newest first
Class II · Moderate risk

Aminophylline active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-514-2015
Class II · Moderate risk

Aminophylline 2.5% Injection

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Ongoing Sterility / contamination Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-700-2013
Class II · Moderate risk

Aminophylline 25mg/ml 10ml

The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.

Terminated Other Main Street Family Pharmacy, LLC D-040-2014
Class II · Moderate risk

Aminophylline 250mg 10ml

The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.

Terminated Other Main Street Family Pharmacy, LLC D-039-2014
Class II · Moderate risk

Aminophylline 20ml

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1455-2012